Trial intelligence / Profile preview

Effect of systemic esmolol infusion on blood loss in posterior lumbar internal fixation surgery

KCT0005133Phase 4Completed

Sponsor
Seoul St. Mary's Hospital
Start
Aug 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of esmolol in lumbar intervertebral disc degenerative disease (LDDD), sponsored by Seoul St. Mary's Hospital. Started Aug 2019; status: completed.

02

Drugs

esmolol
03

Conditions

lumbar intervertebral disc degenerative disease (LDDD)

Beyond the preview

Go deeper on KCT0005133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0005133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call